News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: BGI Tech To Stage Hong Kong IPO


3/3/2014 9:10:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

March 1, 2014 --BGI Tech, the contract sequencing division of Shenzhen genomics sequencing company BGI, is planning a $400 million IPO in Hong Kong late in 2014; Bayer AG will acquire Dihon Pharmaceutical Group of China, a OTC and TCM healthcare products company; Shanghai Shyndec Pharma will purchase the 30% stake in Sinopharm Rongsheng it doesn’t already own for $48.8 million; Shanxi Taxus Pharmaceutical will pay $5 million to acquire an 80%-90% stake in an unnamed California therapeutics company; Essex Medipharma signed an agreement with Pfizer to be the exclusive importer and distributor in China for two types of Pfizer eye drops; China introduced new M&A review procedures that will shorten approval times for “simple” transactions to 30 days; and China's pharmaceutical output in 2013 rose 18% to $355.4 billion, while profits were up 17.6% at $36 billion. More details….

Stock Symbols: (XETRA: BAYN) (SHA: 600420) (HK: 1061) (NYSE: PFE)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES